It is a pharma public limited company based in Moga, Punjab, India, established in 1991.
1991 | Moga, Punjab, India | ActiveFortune Drugs Limited, a active public limited company, was established on 24 April 1991 in Moga, Punjab, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232PB1991PLC011297. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.25 Cr and a paid-up capital of ₹1.25 Cr.
It upholds a compliant status. Its leadership includes Sohrab Singh Gill (Director), Abani Gill (Director), Jasjit Gill (Managing Director). Past directors included Pankaj Nandwana, Sohrab Singh Gill, Shiv Shankar Nandwana. It holds ₹2.47 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Mehmamali Road, Behind Focal Point, Moga, Punjab.
U24232PB1991PLC011297
011297
24 April 1991
₹1.25 Cr
₹1.25 Cr
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Fortune Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sohrab Singh Gill | Director | 07 May 2019 | Current |
| Abani Gill | Director | 31 May 2018 | Current |
| Jasjit Gill | Managing Director | 02 Jul 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 May 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 25 May 2018 | Past |
| Pramod Abcsdd | Director | 07 May 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 25 May 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Fortune Drugs Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 48.86% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
In 2022, Fortune Drugs had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹24,660,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Dec 1996 | Punjab State Ind. Development Corp. Ltd. | ₹5.00 M | Open |
| 04 Dec 1996 | Punjab State Ind. Development Corp. Ltd. | ₹1.00 Cr | Open |
| 09 Feb 1994 | Canara Bank | ₹1.20 M | Open |
| 17 Sep 1992 | Punjab Financial Corporation | ₹8.46 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Fortune Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Fortune Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fortune Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Fortune Drugs Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Fortune Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was recorded as a recent event.
The activity Sohrab Singh Gill was appointed as a Director was appointed as a Director on 07 May 2019 & has been associated with this company since 6 years 6 months . was completed.
Abani Gill was appointed as a Director was appointed as a Director on 31 May 2018 & has been associated with this company since 7 years 6 months . was recorded as a recent event.
Jasjit Gill was appointed as a Managing Director was appointed as a Managing Director on 02 Jul 2012 & has been associated with this company since 13 years 5 months . was recorded as a recent event.
The activity A charge with Punjab State Ind. Development Corp. Ltd. of Rs. 0.50 Cr registered on 04 Dec 1996 with Charge ID 90170783 was modified on 23 Jan 1997. was completed.
The CIN of Fortune Drugs Limited is U24232PB1991PLC011297.
Fortune Drugs Limited is headquartered at Mehmamali Road, Behind Focal Point, Moga, Punjab.
Fortune Drugs Limited was incorporated on 24 April 1991.
The current directors of Fortune Drugs Limited are
The primary industry of Fortune Drugs Limited is Manufacturing.
Fortune Drugs Limited is unlisted.
The authorized capital of Fortune Drugs Limited is ₹1.25 Cr, and the paid-up capital is ₹1.25 Cr.
The compliance status of Fortune Drugs Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX